 Connection
Steven Rosenberg to Lung Neoplasms
This is a "connection" page, showing publications Steven Rosenberg has written about Lung Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.350 |
|
|
|
-
Tran E, Robbins PF, Lu YC, Prickett TD, Gartner JJ, Jia L, Pasetto A, Zheng Z, Ray S, Groh EM, Kriley IR, Rosenberg SA. T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. N Engl J Med. 2016 Dec 08; 375(23):2255-2262.
Score: 0.217
-
Hanada KI, Zhao C, Gil-Hoyos R, Gartner JJ, Chow-Parmer C, Lowery FJ, Krishna S, Prickett TD, Kivitz S, Parkhurst MR, Wong N, Rae Z, Kelly MC, Goff SL, Robbins PF, Rosenberg SA, Yang JC. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. Cancer Cell. 2022 05 09; 40(5):479-493.e6.
Score: 0.079
-
Rosenberg SA, Tran E, Robbins PF. T-Cell Transfer Therapy Targeting Mutant KRAS. N Engl J Med. 2017 02 16; 376(7):e11.
Score: 0.055
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|